4//SEC Filing
NEWHALL CHARLES W III 4
Accession 0001104659-23-119962
CIK 0001356576other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 5:00 PM ET
Size
8.4 KB
Accession
0001104659-23-119962
Insider Transaction Report
Form 4
NEWHALL CHARLES W III
Director10% Owner
Transactions
- Exercise/Conversion
Common Stock
2023-11-16$9.24/sh+7,457$68,903→ 119,589 total - Exercise/Conversion
Director Stock Option (Right to Buy)
2023-11-16−7,457→ 0 totalExercise: $9.24From: 2015-01-21Exp: 2024-01-21→ Common Stock (7,457 underlying) - Sale
Common Stock
2023-11-16$28.01/sh−2,500$70,025→ 117,089 total
Footnotes (1)
- [F1]Represents the number of shares of common stock sold to cover the exercise price of the employee stock options.
Documents
Issuer
SUPERNUS PHARMACEUTICALS, INC.
CIK 0001356576
Entity typeother
Related Parties
1- filerCIK 0001005544
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 5:00 PM ET
- Size
- 8.4 KB